COVID-19-associated Mucormycosis: A clinico-epidemiological study
Observational Study
[키워드] Admission
age
alkaline phosphatase
Antibiotics
Antifungal treatment
Blood Group
Chronic kidney disease
COVID-19
COVID-19 illness
death
diabetes
diagnosed
disease
eight
enrolled
epidemiological
expected
Follow-up
Frequency
hyperglycemia
increase in
India
Ivermectin
Mortality
much lower
Mucormycosis
occurred
Oxygen therapy
pandemic
Patient
patients died
Pneumonia
Posaconazole
positive
raised
required
risk factor
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 RT-PCR
serology
serum creatinine
significantly
steroid
Steroids
survived
the patient
Treatment
uncontrolled
use of antibiotics
ventilator
was done
Zinc
zinc supplementation
[DOI] 10.1016/j.jdiacomp.2022.108284 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.jdiacomp.2022.108284 PMC 바로가기 [Article Type] Observational Study